drugs

Digital health tools that allow providers to electronically prescribe controlled medications can improve care management and curb drug misuse if...

The district court recently remanded remedy decisions to HHS for its underpayments related to the 340B drug pricing program.

The 340B program requires drug manufacturers to provide outpatient drugs to eligible healthcare organizations and other covered entities at significantly...

HHS released a proposed rule outlining changes it wishes to make to the 340B administrative dispute resolution process.

A new study says drug companies reduce access to care by limiting 340B community pharmacies.

In the second of a two-part interview, Brian Clear MD, chief medical officer of Bicycle Health, talks about treatment details...

A decade-long process to secure the safety and security of the pharmaceutical supply chain is nearing the finish line.

Forty-four percent of hospitals view the 340B Drug Pricing Program as a critical revenue source.

Researchers have compared Medicare Part D generic drug pricing with pricing at the Mark Cuban Cost Plus Drug Company.

Congress, purchasers, and industry analysts weighed in on the role pharmacy benefit managers play in prescription drug costs.

Clinical trial innovation must be patient-centered, inclusive, and tech-enabled.

One Michigan plan is bringing predictive power to patient drug treatment.